9.47
+8.11%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About OptimizeRx
From its filings with the US Securities and Exchange Commission
OptimizeRx is based in Waltham, Massachusetts and is incorporated in Nevada. Its shares trade on Nasdaq under the ticker OPRX. The SEC classifies its business as business services, nec. In the fiscal year to 31 December 2025, it reported revenue of $109.4m and net income of $5.1m. At that date it held total assets of $176.9m and shareholders' equity of $128.3m.
OptimizeRx is a leading digital healthcare technology company that is redefining how life sciences brands engage with, market their services and products to, and support patients and healthcare providers. We leverage our proprietary technology solutions and partnerships to help our clients develop and execute highly individualized and targeted marketing campaigns to drive physician and patient engagement and to enhance patient care. OptimizeRx is a Nevada corporation and was founded in 2006 in Rochester, Michigan, as a healthcare technology company delivering various types of messages to target audiences, including coupons and co-pays directly to physicians and pharmacists through electronic health record (“EHR”) systems and ePrescribing (“eRx”) platforms. Over time, the demand for different types of communication and marketing solutions among life sciences organizations, healthcare professionals (“HCPs”), and patients led us to expand upon our initial solution to increase the variety of health-related information we deliver, as well as the platforms, technology, and audiences through, and to which we deliver.
Quoted from its 10-K, filed 12 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 18 May 2005
- Employees
- 104
- Website
- optimizerx.com ↗
- Head office
- 260 CHARLES STREET, WALTHAM, MA, 02453
- Incorporated in
- NV
- Classification
- Services-Business Services, NEC
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Ms. Lynn VosIndependent Chairperson of the Board$248,999
- Mr. Stephen SilvestroPresident, Chief Executive Officer, Director, since 2019$973,132
- Mr. Edward StelmakhChief Financial & Strategic Officer$1.0m
- Mr. Brendan MerrellChief Operating Officer
- Ms. Marion Odence-FordGeneral Legal Officer and Chief Human Resources Officer$2.5m
- Mr. Doug BeschChief Product Officer and Chief Technology Officer
- Mr. Andy D'SilvaChief Business Officer
- Ms. Theresa GrecoChief Commercial Officer
- Ms. Catherine KlemaIndependent Director$206,499
- Mr. James LangIndependent Director$203,999
- Mr. Patrick SpanglerIndependent Director$214,999
- Mr. Gregory WassonIndependent Director$194,999
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 63
- Environment
- 23
- Social
- 87
- Governance
- 79
- Direct emissions (scope 1)
- 2.89 t
- Energy emissions (scope 2)
- 13.6 t
- Women in the workforce
- 44%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- OPTIMIZERx Corp has several key strengths that contribute to its success in the market. Firstly, the company offers innovative and leading-edge technology solutions in the healthcare industry, providing a competitive advantage over its competitors. Additionally, OPTIMIZERx Corp has established strong strategic partnerships with hospitals, healthcare providers, and pharmaceutical companies, enabling it to expand its customer base and enhance its product offerings. Furthermore, the company has a dedicated and skilled workforce, fostering a culture of innovation, collaboration, and customer-centricity.
Weaknesses
- Despite its strengths, OPTIMIZERx Corp also faces certain weaknesses that can hinder its growth and market position. One notable weakness is the dependence on a limited number of major clients for a significant portion of its revenue. This vulnerability exposes the company to potential risks, such as losing key clients or facing pricing pressures. Moreover, OPTIMIZERx Corp operates in a highly competitive market, where disruptive technologies and emerging companies pose a threat to its market share. The company needs to continuously invest in research and development to stay ahead of the competition.
Opportunities
- OPTIMIZERx Corp has identified several opportunities that can drive future growth and profitability. The increasing adoption of digital healthcare solutions presents a promising opportunity for the company to expand its customer base and enhance its product portfolio. Moreover, the growing focus on personalized medicine and patient-centric care provides a platform for OPTIMIZERx Corp to develop tailored and targeted solutions that address specific patient needs. Additionally, the company can explore strategic partnerships with telehealth providers, electronic health record vendors, and other stakeholders in the healthcare ecosystem to leverage synergies and expand its market reach.
Threats
- OPTIMIZERx Corp operates in an industry that faces various threats, which can impact its operations and financial performance. One significant threat is the strict regulatory environment in the healthcare sector. Compliance with existing and new regulations can increase the company's operational costs, hinder product development, and slow down market penetration. Additionally, the constantly evolving technology landscape poses a threat, as competitors can develop similar or superior solutions, challenging OPTIMIZERx Corp's market position. Economic downturns and budget constraints in the healthcare industry can also lead to reduced spending on technology solutions, affecting the company's revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.